A non-steroidal MRA in T2DM and CKD: Interpreting findings of studies10' education - Feb. 1, 2022 - Prof. George Bakris, MD (Chicago, IL, USA), prof. Betram Pitt, MD (Ann Arbor, MI, USA) and prof. Rajiv Agarwal, MD (Indianapolis, IN, USA) - Online CME
Video navigation menu
- Overview of the FIGARO-DKD trial 0:26
- Impact of results on clinical practice 4:52
- Overview of the FIDELITY analysis 7:31
- Discussion 10:11
This video was developed by our partner, ReachMD, a leading online learning platform for physicians and other healthcare professionals.
George L. Bakris, Professor of Medicine and Director of Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, IL, USA.
Bertram Pitt is Professor of Internal Medicine at the University of Michigan School of Medicine in Ann Arbor, MI, USA.
Rajiv Agarwal, MD, MBBS, FASN is Professor of Medicine at Indiana University School of Medicine at Indianapolis, IN, USA.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of EPCCS.
Funding for this educational program was provided by and independent educational grant from Bayer AG.